Skip to main content
. 2004 Jul 20;4:38. doi: 10.1186/1471-2407-4-38

Table 4.

Summary of the response of 35 evaluated patients, divided into CR, PR, SD and PD.

Response No.(%)
Complete Response 4 (11)
Partial Response 7 (20)
Overall Response Rate (CR+PR) 11 (31)
Stable disease 15 (43)
Tumor control rate (CR+PR+SD) 26 (74)
Progressive disease 9 (26)